The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 8 December 2004, www.theannals.com, DOI 10.1345/aph.1E159.
The Annals of Pharmacotherapy: Vol. 39, No. 1, pp. 169-172. DOI 10.1345/aph.1E159
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finch, C. K
Right arrow Articles by Lobo, B. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finch, C. K
Right arrow Articles by Lobo, B. L

Acute Inhalant-Induced Neurotoxicity with Delayed Recovery

Christopher K Finch, PharmD BCPS

Critical Care Specialist, Methodist University Hospital, Memphis, TN; Assistant Professor, College of Pharmacy, University of Tennessee, Memphis

Bob L Lobo, PharmD BCPS

Internal Medicine and Neuroscience Specialist, Methodist University Hospital; Associate Professor, College of Pharmacy, University of Tennessee

Reprints: Dr. Finch, Department of Pharmacy, Methodist University Hospital, 1265 Union Ave., Memphis, TN 38104-3499, fax 901/726-8178, finchc{at}methodisthealth.org

OBJECTIVE: To report a case of neurotoxicity and subsequent hospitalization due to abuse of an ethyl chloride inhalant.

CASE SUMMARY: A 41-year-old African American male presented to the emergency department due to mental status changes and an inability to walk. After the blood alcohol and urine drug screen returned negative, a family member revealed that the patient frequently abused an inhalant containing the volatile solvent ethyl chloride.

DISCUSSION: Inhalant abuse is common and is facilitated by the widespread availability of volatile solvents that have legitimate commercial or household uses. Most inhalants are central nervous system depressants and are highly lipophilic. Maximum Impact, which contains ethyl chloride, is sold in stores and is readily available over the Internet. While the product has a legitimate use as a VCR head cleaner, it is often illicitly marketed over the Internet as a means of getting a "rush" or "high" and for enhancing sexual pleasure. Neurologic symptoms have been reported after deliberate inhalational exposure to ethyl chloride, and 2 deaths have been associated with its use. An objective causality assessment using the Naranjo probability scale revealed a probable adverse drug event.

CONCLUSIONS: Inhalants should be included in the differential diagnosis of patients presenting with acute mental status changes and neurologic impairment that resolve over less than one week.

Key Words: ethyl chloride, inhalant abuse, neurotoxicity

Published Online, December 8, 2004. www.theannals.com, DOI 10.1345/aph.1E159





homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.